ASML vs BGIN

ASML exhibits strong financial health with a Piotroski F-Score of 4/9, indicating stable fundamentals despite not reaching the 'strong' threshold. The company's robust profitability metrics—especially a 50.46% ROE and 29.42% profit margin—underscore its operational excellence. While the current price of $1,345.69 trades at a premium to both the Graham Number ($193.99) and Intrinsic Value ($507.83), this is justified by exceptional growth prospects and dominant market positioning in semiconductor equipment. The recent earnings beat rate of 50% over the last four quarters and consistent positive surprises support a bullish outlook. The absence of an Altman Z-Score does not indicate distress risk, as the company maintains a low debt-to-equity ratio (0.24) and strong liquidity. Price trades at a 28.2% premium to fair value estimate ($1050.00), limiting near-term upside from a valuation perspective.

The company exhibits weak financial health with a Piotroski F-Score of 4/9, indicating marginal stability at best, while the absence of an Altman Z-Score prevents a full distress risk assessment. BGIN is unprofitable, with a negative profit margin of -28.17% and an operating margin of -88.65%, alongside a sharp year-over-year revenue decline of 67%. Despite a strong current ratio of 3.06, liquidity is questionable due to a low quick ratio of 0.62 and missing cash flow data. Valuation metrics are elevated relative to peers, with no earnings to support P/E or PEG analysis, and the stock has underperformed significantly over the past year despite a recent one-month rebound.